Join us as we reveal the findings of the latest MLO State of the Industry (SOI) survey on molecular diagnostics.  The results revealed insights on laboratories' use of molecular testing for COVID-19 diagnosis and variant tracking, repurposing of excess platform capacity for other in-house assays, and their use of technologies in conjunction with molecular testing (e.g., PCR/RT-PCR, NGS) for clinical diagnosis.